New Studies
Major findings from Lancet, BMJ, NEJM, JAMA, and other leading journals
First In Vivo CRISPR Gene Editing Treatment Shows Promise for Rare Blood Disorder
First clinical trial of in vivo CRISPR gene editing for hereditary angioedema shows promising results. The investigational therapy targets genetic…
Editor's Top Picks
Minocycline Stroke Trial Debate Highlights Neuroprotection Research Challenges
Scientific debate in The Lancet highlights persistent challenges in stroke neuroprotection research following criticism of the EMPHASIS minocycline trial. Researchers…
Submit Your Paper →
More form New Studies
Two Weather Patterns Linked to Increased Headache Risk in New Study
University of Cincinnati researchers, collaborating with Mount Sinai, Errex Inc., and Teva Pharmaceuticals, have identified…
Cancer’s Stealth Strategy Backfires, Creating New Therapeutic Target
Groundbreaking research reveals that cancer cells' common strategy to evade immune detection actually makes them…
New Treatment Shows Promise Against Aggressive Jaw Tumour
Researchers report successful targeting of Wnt–β-catenin pathway in recurrent jaw tumour. New molecular approach offers…
Early and Late Puberty in Boys May Signal Future Health Risks, Research Shows
New research reveals that the timing of puberty in boys may predict long-term health risks,…
One in Four Vulnerable Youth Experience Online Abuse, New Study Reveals
New research from the Child Mind Institute reveals that 25% of young people with mental…